Parallel Advisors’s Akero Therapeutics AKRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
5,166
-3
| -0.1% | -$160 | 0.01% | 862 |
|
|
2025
Q1 | $219K | Sell |
5,169
-370
| -7% | -$15.7K | ﹤0.01% | 915 |
|
|
2024
Q4 | $154K | Buy |
5,539
+3
| +0.1% | +$83 | ﹤0.01% | 1052 |
|
|
2024
Q3 | $159K | Hold |
5,536
| – | – | ﹤0.01% | 1023 |
|
|
2024
Q2 | $130K | Buy |
5,536
+26
| +0.5% | +$610 | ﹤0.01% | 1055 |
|
|
2024
Q1 | $139K | Sell |
5,510
-76
| -1% | -$1.92K | ﹤0.01% | 1023 |
|
|
2023
Q4 | $130K | Buy |
5,586
+76
| +1% | +$1.78K | ﹤0.01% | 1002 |
|
|
2023
Q3 | $279K | Hold |
5,510
| – | – | 0.01% | 650 |
|
|
2023
Q2 | $257K | Sell |
5,510
-250
| -4% | -$11.7K | 0.01% | 678 |
|
|
2023
Q1 | $220K | Sell |
5,760
-23
| -0.4% | -$880 | 0.01% | 724 |
|
|
2022
Q4 | $317K | Sell |
5,783
-250
| -4% | -$13.7K | 0.01% | 538 |
|
|
2022
Q3 | $205K | Buy |
6,033
+2,116
| +54% | +$71.9K | 0.01% | 670 |
|
|
2022
Q2 | $37K | Buy |
+3,917
| New | +$37K | ﹤0.01% | 1390 |
|